The Global bleeding disorder testing market demand is expected to increase at a 7.2% CAGR from 2023 to 2033, according to a recent FMI analysis. By the end of the assessment period, the market is expected to be worth US$ 190 billion. The need for testing for bleeding disorders will increase along with the incidence of liver diseases, anaemia, and other issues with blood coagulation.
A clump of platelets and a specific type of blood cell forms in the affected body location. This clot keeps infections out of the bloodstream and prevents blood from draining from the injured area. Testing for bleeding disorders can help determine whether specific clotting factors are present and how long it takes for blood to clot.
Request a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15961
The test measures the time it takes for the arteries to contract and platelets in the blood to close the opening. According to the National Haemophilia Foundation, Von Willebrand disease is the most common bleeding disorder, affecting around one in every 100 people, up to 1% of the US population.
Key Takeaways:
- According to FMI, the Global Bleeding Disorder Testing market will grow by 7.2% CAGR by 2033.
- The global bleeding disorder testing industry is predicted to be worth $ 95 billion.
- The global bleeding disorder testing industry is anticipated to be worth US$ 190 billion.
- North America is expected to be the most profitable market for Bleeding Disorder Testing growth.
- According to Future Market Insights, Asia Pacific is predicted to develop at a CAGR of 6.5% from 2023 to 2033.
- Europe is predicted to increase at a CAGR of 6.9% between 2023 and 2033.
- In the forecast period 2023 to 2033, the diagnostic centres category is estimated to hold the greatest market share for Bleeding Disorder Testing.
The North American market is expected to expand significantly throughout the projected period. The increase can be attributed to the increased availability of testing devices and the rising number of regulatory approvals,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI) analyst.
Unlock Exclusive Insights Now and Gain a Competitive Edge in Bleeding Disorder Testing Market! Act Fast to Secure Unbeatable Discounts: https://www.futuremarketinsights.com/checkout/15961
Bleeding Disorder Testing Market Growth:
Increasing Blood Disorder Prevalence to Improve Maintenance and Performance
Chronic illness includes blood issues. They are also hazardous since they circulate in the blood. The prevalence of conditions such as liver disease, anemia, and other blood coagulation concerns has increased, as has the demand for bleeding disorders testing. These inherited diseases resulted in a profitable market expansion.
Government Investments in Healthcare Interoperability Have an Impact on the Market
The increasing funding provided by the federal government to encourage the use of these solutions has an additional impact on the sector. Furthermore, rising healthcare spending, advancements in healthcare infrastructure, and rising need for long-term care delivery all benefit the bleeding disorders testing sector, promoting market expansion.
Key players:
- Siemens Healthcare GmbH
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Atlas Medical GmbH
- Horiba Ltd.
- Hyphen Bio Med
- Precision Biologics Incorporated
- Pfizer Inc.
- Baxter
Recent Developments:
- In March 2021, F. Hoffmann La Roche Ltd. introduced eight new configurations for Cobas pro integrated solutions, with the goal of increasing throughput and testing efficiency.
Bleeding Disorder Testing Market Segmentation:
Bleeding Disorder Testing Market by Product Type:
- Reagents & Consumables
- Instruments
Bleeding Disorder Testing Market by Indication:
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease
- Idiopathic Thrombocytopenic Purpura
- Others
Bleeding Disorder Testing Market by End User:
- Hospitals & Clinics
- Diagnostic Centers
- Others
Bleeding Disorder Testing Market by Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa
Originally Published By: https://www.chronicles24.com/index.php/2023/10/04/bleeding-disorder-testing-market-set-to-surge-anticipated-to-reach-us-190-billion-by-2033-future-market-insights-inc/
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
At-home Molecular Testing Market Analysis: The at-home molecular testing market size is projected to be worth US$ 10.2 billion in 2023. The market is likely to surpass US$ 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period.
Nucleic Acid Testing Market Sales: The global nucleic acid testing market size is set to reach US$ 3.7 billion in 2023. Overall sales of nucleic acid testing are likely to surge at 6.8% CAGR, taking the forecasted market valuation to US$ 7.2 billion by the end of 2033.
Hemophilia Treatment Market Outlook: The global hemophilia treatment market size was estimated to be worth around US$ 11.1 Billion in 2021. However, with a rapidly increasing hemophilia patient pool worldwide and advancements in hemophilia treatment approaches, the overall demand for hemophilia treatment is projected to rise at 4.8% CAGR during the forecast period, surpassing a valuation of US$ 17.92 Billion by the end of 2032.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
